BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11211927)

  • 21. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic pathways of gallbladder mucosal prostanoids: the role of cyclooxygenase-1 and 2.
    Longo WE; Panesar N; Mazuski JE; Kaminski D
    Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):77-85. PubMed ID: 10328326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production.
    Tao X; Schulze-Koops H; Ma L; Cai J; Mao Y; Lipsky PE
    Arthritis Rheum; 1998 Jan; 41(1):130-8. PubMed ID: 9433878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
    Giuliano F; Warner TD
    Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases.
    Buccellati C; Sala A; Ballerio R; Bianchib M
    Eur J Pain; 2000; 4(4):413-5. PubMed ID: 11124014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
    Moalic S; Liagre B; Le Bail JC; Beneytout JL
    Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of non-steroidal anti-inflammatory drugs on prostaglandin E2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide.
    Nakatsugi S; Sugimoto N; Furukawa M
    Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):451-7. PubMed ID: 9014225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA
    Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?
    James MJ; Penglis PS; Caughey GE; Demasi M; Cleland LG
    Inflamm Res; 2001 May; 50(5):249-53. PubMed ID: 11409487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
    Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
    J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
    McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
    Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
    J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung.
    Amann R; Schuligoi R; Peskar BA
    Inflamm Res; 2001 Jan; 50(1):50-3. PubMed ID: 11235022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
    Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
    Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat.
    Harada Y; Kawamura M; Hatanaka K; Saito M; Ogino M; Ohno T; Ogino K; Yang Q
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):345-58. PubMed ID: 9653772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the cyclooxygenase-2 inhibitor NS-398 on thromboxane and leukotriene synthesis in rat peritoneal cells.
    Schuligoi R; Amann R; Prenn C; Peskar BA
    Inflamm Res; 1998 May; 47(5):227-30. PubMed ID: 9657255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 is upregulated in inflamed gingival tissues.
    Morton RS; Dongari-Bagtzoglou AI
    J Periodontol; 2001 Apr; 72(4):461-9. PubMed ID: 11338298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases.
    Panara MR; Greco A; Santini G; Sciulli MG; Rotondo MT; Padovano R; di Giamberardino M; Cipollone F; Cuccurullo F; Patrono C
    Br J Pharmacol; 1995 Nov; 116(5):2429-34. PubMed ID: 8581280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.